The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania
Clinical trial NCT00216554 · COMPLETED
Trial details
- NCT number
- NCT00216554
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.